Skip to main content
SpringerLink
Log in

Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells

  • Research Articles
  • Drug Actions
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Alpha-synuclein (α-SYN) is a small and highly conserved presynaptic protein that is implicated in both normal brain function and the pathogenesis of neurodegenerative diseases. Although the physiological function of α-SYN has not been fully evaluated, several lines of evidence suggest that it plays an important role in the regulation of dopamine homeostasis in the brain. Early studies have demonstrated that interaction of α-SYN and tyrosine hydroxylase (TH), a rate-limiting enzyme in dopamine synthesis, is functionally significant for dopaminergic neurotransmission and the pathophysiology of Parkinson’s disease. In the present study, we would like to evaluate whether overexpression of wild-type or mutant α-SYN might affect cAMP/PKA-dependent TH activation in DA-producing SK-N-BE(2)C cells. Here we show that wild-type and mutant A30P and A53T α-SYN attenuate forskolin-induced TH up-regulation, but do not suppress TH basal expression in SK-N-BE(2)C cells. Forskolin-induced increase in TH promoter activity and CRE-dependent transcription are significantly suppressed in α-SYN-overexpressing cells. Alpha-SYN enters the nucleus, but does not bind to CREB or interfere with forskolin-induced CREB phosphorylation. These data indicate that elevated levels of α-SYN due to a specific disease or the normal aging process could be associated with dopaminergic neuronal dysfunction through interference with TH regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W. H., Castillo, P. E., Shinsky, N., Verdugo, J. M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D., and Rosenthal, A., Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239–252 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Carlezon, W. A. Jr., Duman, R. S., and Nestler, E. J., The many faces of CREB. Trends Neurosci., 28, 436–445 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Chae, S. W., Bang, Y. J., Kim, K. M., Lee, K. Y., Kang, B. Y., Kim, E. M., Inoue, H., Hwang, O., and Choi, H. J., Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation. Biochem. Biophys. Res. Commun., 359, 735–741 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Chu, Y., Kompoliti, K., Cochran, E. J., Mufson, E. J., and Kordower, J. H., Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J. Comp. Neurol., 450, 203–214 (2002).

    Article  PubMed  CAS  Google Scholar 

  • DeMarch, Z., Giampà, C., Patassini, S., Martorana, A., Bernardi, G., and Fusco, F. R., Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Neurobiol. Dis., 25, 266–273 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Døskeland, A. P. and Flatmark, T., Recombinant human phenylalanine hydroxylase is a substrate for the ubiquitinconjugating enzyme system. Biochem. J., 319 (Pt 3), 941–945 (1996).

    PubMed  Google Scholar 

  • Dunkley, P. R., Bobrovskaya, L., Graham, M. E., von Nagy-Felsobuki, E., and Dickson, P. W., Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem., 91, 1025–1043 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Emborg, M. E., Ma, S. Y., Mufson, E. J., Levey, A. I., Taylor, M. D., Brown, W. D., Holden, J. E., and Kordower, J. H., Agerelated declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J. Comp. Neurol., 401, 253–265 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Flatmark, T., Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol. Scand., 168, 1–17 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Goers, J., Manning-Bog, A. B., McCormack, A. L., Millett, I. S., Doniach, S., Di Monte, D. A., Uversky, V. N., and Fink, A. L., Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry, 42, 8465–8471 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Haycock, J. W., Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem., 265, 11682–11691 (1990).

    PubMed  CAS  Google Scholar 

  • Hegde, M. L., Vasudevaraju, P., and Rao, K. J., DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson’s disease. Front Biosci., 15, 418–436 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Impey, S., McCorkle, S. R., Cha-Molstad, H., Dwyer, J. M., Yochum, G. S., Boss, J. M., McWeeney, S., Dunn, J. J., Mandel, G., and Goodman, R. H., Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell, 119, 1041–1054 (2004).

    PubMed  CAS  Google Scholar 

  • Jakes, R., Spillantini, M. G., and Goedert, M., Identification of two distinct synucleins from human brain. FEBS Lett., 345, 27–32 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Kim, K. S., Lee, M. K., Carroll, J., and Joh, T. H., Both the basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cAMP response element. J. Biol. Chem., 268, 15689–15695 (1993).

    PubMed  CAS  Google Scholar 

  • Kontopoulos, E., Parvin, J. D., and Feany, M. B., Alphasynuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet., 15, 3012–3023 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schöls, L., and Riess, O., Ala30Pro mutation in the gene encoding alphasynuclein in Parkinson’s disease. Nat. Genet., 18, 106–108(1998).

    Article  PubMed  Google Scholar 

  • Kumer, S. C. and Vrana, K. E., Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem., 67, 443–462 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Lazaroff, M., Qi, Y., and Chikaraishi, D. M., Differentiation of a catecholaminergic CNS cell line modifies tyrosine hydroxyl-ase transcriptional regulation. J. Neurochem., 71, 51–59 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Lee, F. J., Liu, F., Pristupa, Z. B., and Niznik, H. B., Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J., 15, 916–926 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Lindgren, N., Xu, Z. Q., Lindskog, M., Herrera-Marschitz, M., Goiny, M., Haycock, J., Goldstein, M., Hökfelt, T., and Fisone, G., Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum. J. Neurochem., 74, 2470–2477 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Lotharius, J. and Brundin, P., Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson’s disease. Hum. Mol. Genet., 11, 2395–2407 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Mayr, B. and Montminy, M., Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol., 2, 599–609 (2001).

    Article  PubMed  CAS  Google Scholar 

  • McNaught, K. S., Olanow, C. W., Halliwell, B., Isacson, O., and Jenner, P., Failure of the ubiquitin-proteasome system in Parkinson’s disease. Nat. Rev. Neurosci., 2, 589–594 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Melia, K. R., Rasmussen, K., Terwilliger, R. Z., Haycock, J. W., Nestler, E. J., and Duman, R. S., Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. J. Neurochem., 58, 494–502 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Mosharov, E. V., Staal, R. G., Bové, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K. E., Moore, C. M., Troyer, M. D., Edwards, R. H., Przedborski, S., and Sulzer, D., Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J. Neurosci., 26, 9304–9311 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., and Sulzer, D., Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron, 62, 218–229 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Naoi, M. and Maruyama, W., Cell death of dopamine neurons in aging and Parkinson’s disease. Mech. Ageing Dev., 111, 175–188 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., and Wolozin, B., alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci., 19, 5782–5791 (1999).

    PubMed  CAS  Google Scholar 

  • Peng, X., Tehranian, R., Dietrich, P., Stefanis, L., and Perez, R. G., Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J. Cell Sci., 118, 3523–3530 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., and Zigmond, M. J., A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci., 22, 3090–3099 (2002).

    PubMed  CAS  Google Scholar 

  • Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L., Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science, 276, 2045–2047 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Ramsey, A. J. and Fitzpatrick, P. F., Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: evidence for a novel regulatory mechanism. Biochemistry, 37, 8980–8986 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Reesink, F. E., Lemstra, A. W., Van Dijk, K. D., Berendse, H. W., Van de Berg, W. D., Klein, M., Blankenstein, M. A., Scheltens, P., Verbeek, M. M., and van der Flier, W. M., CSF α-Synuclein does not discriminate dementia with lewy bodies from Alzheimer’s disease. J. Alzheimers Dis., 22, 87–95 (2010).

    PubMed  CAS  Google Scholar 

  • Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M., Alpha-synuclein in Lewy bodies. Nature, 388, 839–840 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T., Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A., 90, 11282–11286 (1993).

    Article  PubMed  Google Scholar 

  • Wong, D. L. and Tank, A. W., Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress, 10, 121–130 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Yavich, L., Tanila, H., Vepsäläinen, S., and Jäkälä, P., Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci., 24, 11165–11170 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Yavich, L., Jäkälä, P., and Tanila, H., Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J. Neurochem., 99, 724–732 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Yu, S., Zuo, X., Li, Y., Zhang, C., Zhou, M., Zhang, Y. A., Uéda, K., and Chan, P., Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci. Lett., 367, 34–39 (2004).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, 500-757, Korea

    Sa Suk Kim, Kyung Rok Moon & Hyun Jin Choi

  2. College of Pharmacy, Chonnam National University, 300 Yongbong-Dong, Buk-Gu, Gwangju, 500-757, Korea

    Hyun Jin Choi

Authors
  1. Sa Suk Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyung Rok Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyun Jin Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyun Jin Choi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S.S., Moon, K.R. & Choi, H.J. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells. Arch. Pharm. Res. 34, 837–845 (2011). https://doi.org/10.1007/s12272-011-0518-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-0518-0

Key words

Search

Navigation